Diffuse large B-cell lymphoma (DLBCL) is curable in about two-third of patients with rituximab, cyclophosphamide, adriamycin, vincristine, prednisone (R-CHOP) immunochemotherapy. Risk stratification ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback